Shopping Cart

April 2023 Investor Newsletter

April 2023 Investor Newsletter

We are continuing the momentum from our positive phase 1 trial results and are pleased to have recently released our latest updates in our April Investor Newsletter covering:

🔹 Clinical data and expert review triggers commercial partner outreach efforts
🔹 MRI utility drives new IP and AI/ML efforts
🔹 Upcoming events and a recap on key media coverage

Read the full newsletter: HERE >> 




Questions about this announcement or other investor-related inquiries? Please email our investor relations department at:

Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.